Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Hans-Jürgen, Stellbrink"'
Autor:
Malte Monin, Tim Kümmerle, Jochen Schneider, Christiane Cordes, Hans Heiken, Hans-Jürgen Stellbrink, Ivanka Krznaric, Stefan Scholten, Björn Jensen, Heiko Jessen, Wilfried Obst, Petra Spornraft-Ragaller, Pavel Khaykin, Annamaria Balogh, Eva Wolf, Helen Bidner, Christoph D. Spinner, Christoph Boesecke, on behalf of the DUALIS STUDY GROUP
Publikováno v:
HIV Research & Clinical Practice, Vol 23, Iss 1, Pp 15-21 (2022)
Background/Aims: Switching from a three-drug regimen (3DR: boosted darunavir [bDRV] and two nucleoside reverse transcriptase inhibitors [NRTIs]) to a two-drug regimen (2DR: bDRV and dolutegravir [DTG]) demonstrated non-inferiority with regard to vira
Externí odkaz:
https://doaj.org/article/a20e550effa442568061017841420a2e
Autor:
Paul E. Sax, José R. Arribas, Chloe Orkin, Adriano Lazzarin, Anton Pozniak, Edwin DeJesus, Franco Maggiolo, Hans-Jürgen Stellbrink, Yazdan Yazdanpanah, Rima Acosta, Hailin Huang, Jason T. Hindman, Hal Martin, Jared M. Baeten, David Wohl
Publikováno v:
EClinicalMedicine, Vol 59, Iss , Pp 101991- (2023)
Summary: Background: Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a single-tablet regimen recommended for HIV-1 treatment. The safety and efficacy of B/F/TAF as initial therapy was established in two Phase 3 studies: 1489 (vs dolutegr
Externí odkaz:
https://doaj.org/article/3763c296832847b0809740fb61aeb872
Autor:
Benjamin Maasoumy, Patrick Ingiliz, Christoph D. Spinner, Christiane Cordes, Hans-Jürgen Stellbrink, Julian Schulze zur Wiesch, Stephan M. Schneeweiß, Katja Deterding, Tobias Müller, Julia Kahlhöfer, Petra Dörge, Maria von Karpowitz, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg
Publikováno v:
JHEP Reports, Vol 5, Iss 3, Pp 100650- (2023)
Background & Aims: EASL guidelines recommend 8 weeks of treatment with sofosbuvir plus velpatasvir (SOF/VEL) for the treatment of acute or recently acquired HCV infection, but only 6- and 12-week data are available. Therefore, the aim of this study w
Externí odkaz:
https://doaj.org/article/612f548a04634195960c6a4eb99bc11d
Autor:
Eva Wolf, Christoph Boesecke, Annamaria Balogh, Helen Bidner, Christiane Cordes, Hans Heiken, Ivanka Krznaric, Tim Kümmerle, Hans-Jürgen Stellbrink, Jochen Schneider, Christoph D. Spinner, the DUALIS Study Group
Publikováno v:
AIDS Research and Therapy, Vol 18, Iss 1, Pp 1-5 (2021)
Abstract Objective The DUALIS study showed that switching to boosted darunavir (bDRV) plus dolutegravir (DTG; 2DR) was non-inferior to continuous bDRV plus 2 nucleoside/nucleotide reverse-transcriptase inhibitors (NRTIs; 3DR) in treatment-experienced
Externí odkaz:
https://doaj.org/article/13c3c10b06e24c7ca75268ee1f49479c
Autor:
Katharina Kolbe, Melanie Wittner, Philip Hartjen, Anja-Dorothee Hüfner, Olaf Degen, Christin Ackermann, Leon Cords, Hans-Jürgen Stellbrink, Friedrich Haag, Julian Schulze zur Wiesch
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Backgroundγδ T cells are unconventional T cells that have been demonstrated to be crucial for the pathogenesis and potentially for the cure of HIV-1 infection. The ectonucleotidase CD39 is part of the purinergic pathway that regulates immune respon
Externí odkaz:
https://doaj.org/article/d0ee9ee4359643ebb49a889280b614f9
Autor:
Hans-Jürgen Stellbrink, Torsten Schaller, Kerstin Sturm, Norbert Hermann Brockmeyer, Anja Potthoff, Markus Bickel, Stefan Scholten, Nils Postel, Arne Jessen, Matthias Christian Müller, Dirk Jaeger, Christian Müller, Narges Seyfizadeh, Leonie Jenner, Kevin Moog, Stefan Hans Schöffel, Bernd Ullrich, Laura Brosi, Claudia Kunz, Daniel Thomas, Rico Laage, Frank Hanakam, Oliver Schoenborn-Kellenberger, Marina Mangold, Katharina Och, Thorsten Lehr, Michaela Anja Elisabeth Arndt, Jürgen Krauss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0050342137fe2d7ab0b999b466f8c0b
https://doi.org/10.2139/ssrn.4453382
https://doi.org/10.2139/ssrn.4453382
Autor:
Hans-Jürgen Stellbrink
Publikováno v:
MMW - Fortschritte der Medizin. 163:24-27
Autor:
Kristine M. Erlandson, Chloe Orkin, Grace A. McComsey, Jürgen K. Rockstroh, Laura Waters, Moupali Das, John R. Koethe, Frank A. Post, Hans-Jürgen Stellbrink, Hailin Huang, Hal Martin, Kathleen Melbourne, Xuelian Wei, Stefan Esser, Jordan E. Lake, Todd T. Brown, Christoph C Carter, Paul E. Sax, C Cohen
Publikováno v:
Clinical Infectious Diseases. 73:1440-1451
Background We sought to identify factors associated with weight gain in randomized clinical trials of antiretroviral therapy (ART) switch. Methods We explored the effects of demographic factors, clinical characteristics, and ART on weight gain in a p
Autor:
Elisabeth Olliges, Bernhard Bührlen, Franz Fischer, Christoph Boesecke, Tim Kümmerle, Jochen Schneider, Simon Weidlich, Christiane Cordes, Hans Heiken, Hans-Jürgen Stellbrink, Ivanka Krznaric, Stefan Scholten, Björn Erik-Ole Jensen, Eva Wolf, Joram Ronel, Christoph D. Spinner, null on behalf of the DUALIS STUDY GROUP
Publikováno v:
AIDS Care. 34:698-707
The DUALIS study demonstrated efficacy and safety of switching to dolutegravir plus ritonavir-boosted darunavir (DRV/r) (2DR) as compared to standard-of-care-therapy with two nucleoside reverse transcriptase inhibitors + DRV/r (3DR) in pretreated peo
Autor:
Laura, Waters, Lambert, Assoumou, Ana, González-Cordón, Stefano, Rusconi, Pere, Domingo, Mark, Gompels, Stephane, de Wit, François, Raffi, Christoph, Stephan, Mar, Masiá, Jürgen, Rockstroh, Christine, Katlama, Georg M N, Behrens, Graeme, Moyle, Margaret, Johnson, Julie, Fox, Hans-Jürgen, Stellbrink, Giovanni, Guaraldi, Eric, Florence, Stefan, Esser, José M, Gatell, Anton, Pozniak, Esteban, Martínez
In the NEAT022 trial, virologically suppressed persons with HIV at high cardiovascular risk switching from protease inhibitors to dolutegravir either immediately (DTG-I) or after 48 weeks (DTG-D) showed non-inferior virological suppression and signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b1b9b94fa8d43eac38701bf985d32767
https://hdl.handle.net/11380/1295531
https://hdl.handle.net/11380/1295531